PATH vs TKNO
Uipath Inc (PATH) versus Alpha Teknova Inc (TKNO) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported TKNO revenue for 2024-12-31 was $37.7M. Net income was -$26.7M. Revenue was up 2.9% from 2023-12-31 to 2024-12-31. TKNO currently screens at market cap $221.4M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. TKNO currently screens at market cap $221.4M.
Not investment advice. Open the PATH and TKNO stock pages for the full models.
Not investment advice.